In one move that will please the drug industry, Trump has promised to do away with the detested 'pill penalty', a shorter ...

Click Therapeutics' digital therapeutic (DTx) CT-132 has been approved by the FDA, becoming the first treatment of its type ...

In one move that will please the drug industry, Trump has promised to do away with the detested 'pill penalty', a shorter ...

The policy was the buzz of the International Society for Health Economics and Outcomes Research (ISPOR) annual European ...

Access to UK Biobank data by researchers based in China has sparked headlines in the UK about potential security concerns, ...

Join the TPD & Induced Proximity Pharma Partnering Summit to accelerate partnership interest in your protein degradation ...

Johnson & Johnson has said it expects to see a $400 million financial hit from President Trump's tariffs, which will be felt ...

The EU approval comes after Eisai and Biogen were given approval for a new once-monthly intravenous maintenance dose of ...

AI and digital health have tremendous potential to improve patient outcomes across healthcare, but in rare disease – where small patient groups, delayed diagnosis, and barriers to access create major ...

The pharmaceutical industry is quickly evolving; to stay relevant and competitive, companies need to stay on top of the most recent trends and technologies. One important piece of the puzzle that ...

These have been dark days for the global economy, and the short-term prospects for the pharmaceutical industry look uncertain. The industry is currently undergoing change and restructuring on an ...

In the dark days of 2020, amid the global race for a COVID-19 vaccine, the UK showcased its world-class expertise in medical research. The swift development of the Oxford-AstraZeneca vaccine ...